Cargando…
Development and characterization of polyclonal antibody against human kappa light chain in rabbit
Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in norm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Urmia University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828161/ https://www.ncbi.nlm.nih.gov/pubmed/31737229 http://dx.doi.org/10.30466/vrf.2018.81414.2077 |
_version_ | 1783465368728109056 |
---|---|
author | Esparvarinha, Mojgan Nickho, Hamid Aghebati-Maleki, Leili Abdolalizadeh, Jalal Nasiri, Hadi Valedkarimi, Zahra Majidi, Jafar |
author_facet | Esparvarinha, Mojgan Nickho, Hamid Aghebati-Maleki, Leili Abdolalizadeh, Jalal Nasiri, Hadi Valedkarimi, Zahra Majidi, Jafar |
author_sort | Esparvarinha, Mojgan |
collection | PubMed |
description | Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in normal condition. The purpose of this study was the production and purification of polyclonal immunoglobulin G (IgG) against human kappa light chains. In this study, early human IgG was purified by ion-exchange chromatography, reduced with Dithiothreitol and heavy and light chains were separated with size-exclusion chromatography. Afterward, affinity chromatography with protein L Sepharose at pH 2.00 was displayed to be a dominant condition for the separation and purification of the kappa light chain of immunoglobulins from human serum. Eventually, the rabbit was immunized by human kappa light chains. The rabbit IgG was purified and labeled with horseradish peroxidase (HRP). Direct enzyme-linked immunosorbent assay was planned to determine the titer of HRP conjugated rabbit IgG against the human kappa light chain. The optimum titer of anti-kappa IgG was 1:16000. At the result, purified polyclonal anti-kappa is useful tool in biomedical and biochemical researches and diagnostic kits. |
format | Online Article Text |
id | pubmed-6828161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Urmia University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68281612019-11-15 Development and characterization of polyclonal antibody against human kappa light chain in rabbit Esparvarinha, Mojgan Nickho, Hamid Aghebati-Maleki, Leili Abdolalizadeh, Jalal Nasiri, Hadi Valedkarimi, Zahra Majidi, Jafar Vet Res Forum Original Article Polyclonal antibodies against kappa light chain are used to diagnose diseases producing free light chain. The kappa and lambda light chains are products of immunoglobulin synthesis and released into the circulation in minor amounts such as serum, cerebrospinal fluid, urine and synovial fluid in normal condition. The purpose of this study was the production and purification of polyclonal immunoglobulin G (IgG) against human kappa light chains. In this study, early human IgG was purified by ion-exchange chromatography, reduced with Dithiothreitol and heavy and light chains were separated with size-exclusion chromatography. Afterward, affinity chromatography with protein L Sepharose at pH 2.00 was displayed to be a dominant condition for the separation and purification of the kappa light chain of immunoglobulins from human serum. Eventually, the rabbit was immunized by human kappa light chains. The rabbit IgG was purified and labeled with horseradish peroxidase (HRP). Direct enzyme-linked immunosorbent assay was planned to determine the titer of HRP conjugated rabbit IgG against the human kappa light chain. The optimum titer of anti-kappa IgG was 1:16000. At the result, purified polyclonal anti-kappa is useful tool in biomedical and biochemical researches and diagnostic kits. Urmia University Press 2019 2019-09-15 /pmc/articles/PMC6828161/ /pubmed/31737229 http://dx.doi.org/10.30466/vrf.2018.81414.2077 Text en © 2019 Urmia University. All rights reserved This is an open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License, (https://creativecommons.org/licenses/by-nc/4.0/) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Esparvarinha, Mojgan Nickho, Hamid Aghebati-Maleki, Leili Abdolalizadeh, Jalal Nasiri, Hadi Valedkarimi, Zahra Majidi, Jafar Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title | Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title_full | Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title_fullStr | Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title_full_unstemmed | Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title_short | Development and characterization of polyclonal antibody against human kappa light chain in rabbit |
title_sort | development and characterization of polyclonal antibody against human kappa light chain in rabbit |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828161/ https://www.ncbi.nlm.nih.gov/pubmed/31737229 http://dx.doi.org/10.30466/vrf.2018.81414.2077 |
work_keys_str_mv | AT esparvarinhamojgan developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT nickhohamid developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT aghebatimalekileili developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT abdolalizadehjalal developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT nasirihadi developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT valedkarimizahra developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit AT majidijafar developmentandcharacterizationofpolyclonalantibodyagainsthumankappalightchaininrabbit |